The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Abstract
Context: Berberine, a natural plant alkaloid, is usually used as an antibiotic drug. The potential glucose-lowering effect of berberine was noted when it was used for diarrhea in diabetic patients. In vitro and in vivo studies have then showed its effects on hyperglycemia and dyslipidemia. Objective: The objective of the study was to evaluate the efficacy and safety of berberine in the treatment of type 2 diabetic patients with dyslipidemia. Design: One hundred sixteen patients with type 2 diabetes and dyslipidemia were randomly allocated to receive berberine (1.0 g daily) and the placebo for 3 months. The primary outcomes were changes in plasma glucose and serum lipid concentrations. Glucose disposal rate (GDR) was measured using a hyperinsulinemic euglycemic clamp to assess insulin sensitivity. Results: In the berberine group, fasting and postload plasma glucose decreased from 7.0 ± 0.8 to 5.6 ± 0.9 and from 12.0 ± 2.7 to 8.9 ± 2.8 mm/liter, HbA1c from 7.5 ± 1.0% to 6.6 ± 0.7%, triglyceride from 2.51 ± 2.04 to 1.61 ± 1.10 mm/liter, total cholesterol from 5.31 ± 0.98 to 4.35 ± 0.96 mm/liter, and low-density lipoprotein-cholesterol from 3.23 ± 0.81 to 2.55 ± 0.77 mm/liter, with all parameters differing from placebo significantly (P < 0.0001, P < 0.0001, P < 0.0001, P = 0.001, P < 0.0001, and P <0.0001, respectively). The glucose disposal rate was increased after berberine treatment (P = 0.037), although no significant change was found between berberine and placebo groups (P = 0.063). Mild to moderate constipation was observed in five participants in the berberine group. Conclusions: Berberine is effective and safe in the treatment of type 2 diabetes and dyslipidemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two cases of liver function abnormalities were reported in one study in the berberine group,(29) although two studies reported no increase or a decrease in liver transaminases with berberine.(32, 34)”
From Overall and sex-specific effect of berberine for dyslipidemia: systematic review and meta-analysis of placebo-controlled trials (2022) · cites this paper as [32]
In the citing paper
“Further analysis suggested that this was likely due to most participants in this subgroup having normal blood glucose levels, as berberine does not significantly affect normal values for these indicators (Zhang et al., 2008; An et al., 2014; Wang et al., 2016b).”
From Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials (2025) · cites this paper as Zhang et al., 2008
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,718
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054
Gabir, M. M., Hanson, R. L., Dabelea, D., Imperatore, G., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1108 · Cited by 568
Berberine improves glucose metabolism through induction of glycolysis
Yin, J., Gao, Z., Liu, D., Liu, Z., & Ye, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2007 · Cited by 418
Zuo, F., Nakamura, N., Akao, T., & Hattori, M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011361 · Cited by 284
Leng, S.-H., Lu, F., & Xu, L. (2004) · PubMed · Cited by 237
Flagged first, then by citations
Research works printed but not linked: 3
- Ni, 1988, Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research [article in Chinese]., Zhong Xi Yi Jie He Za Zhi, 8, 711
- Xie, 2005, The clinical efficacy of berberine in treatment of type 2 diabetes mellitus [article in Chinese]., Chin J Clin Healthcare, 8, 402
- Wei, 2004, Clinical study on improvement of type 2 diabetes mellitus complicated with fatty liver treatment by berberine [article in Chinese], Zhong Xi Yi Jie He Ganbing Za Zhi, 14, 334
Cited by
Sorted by citations
Items 501–578 of 578
Network pharmacology approach for antidiabetic drugs from natural sources
Dagar, N., Kulkarni, Y. A., & Gaikwad, A. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30086-8.00015-2 · Cited by 1
Berberine: An Antihypoglycemic Alkaloid
Sharma, A., & Batra, A. (2013) · Journal of Functional And Environmental Botany · doi:10.5958/j.2231-1750.3.2.008 · Cited by 1
Khogta, S., Addepalli, V., Buttar, H. S., & Kaur, G. (2019) · Springer eBooks · doi:10.1007/978-981-13-8763-0_26 · Cited by 1
Biochemical evaluation of newly composed tercumin capsules
Mahmoud, M., Khalifa, Y., & El-Naem, G. A. (2020) · Archives of Agriculture Sciences Journal/Archives of Agriculture Sciences Journal · doi:10.21608/aasj.2020.117469 · Cited by 1
New therapeutic strategies in the management of obesity-modulated inflammation
Tyszkowski, R., & Mehrzad, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90960-0.00006-0 · Cited by 1
The Chloroplast Genome Sequence Characteristics Analysis of Berberis diaphana Maxim
Li, P. (2023) · Open Access Journal of Agricultural Research · doi:10.23880/oajar-16000317 · Cited by 1
Richard, J., Cameron, G., & Tyler, M. (2011) · InTech eBooks · doi:10.5772/22609
“fasting and postprandial blood glucose, HbA1c, triglycerides, total cholesterol, LDL-C, blood pressure and IL-6, compared to placebo (Zhang et al., 2008).”
Background(2013) · Elsevier eBooks · doi:10.1016/b978-0-443-06992-5.00010-4 · Cited by 2
Alam, S. B., Kulka, M., & Wang, Y. (2023) · Preprints.org · doi:10.20944/preprints202302.0238.v1 · Cited by 1
Goetz, P. W. (2016) · Phytothérapie · doi:10.1007/s10298-016-1070-3
Di, Y. (2012) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27332868
Hydrastis canadensis (Goldenseal) and Other Berberine-Containing Botanicals
Murray, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00097-3
Original Article Berberine protected rats against adiposity induced by high-fat diets
Wu, Y., Chen, Z., Huang, X., Liu, J. L., Cha, Y., Wang, F., & Xu, J. (2016)
Sun, N. (2013) · DigitalGeorgetown (Georgetown University Library)
Dietary Supplements, Phytotherapy and Chinese Herbal Medicine in PCOS
Wu, X., & Ng, E. H. Y. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_14
Gyógynövénykivonatok fémelemtartalom-vizsgálatának jelentősége adjuváns terápiában
Szentmihályi, K. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.30955
“A berberin alkaloid szignifikánsan csökkenti az éhgyomri és az étkezés előtti plazmaglükózszintet, a vér HbA1c- és az IL6 szintjét, ami az inzulinérzékenység javulása mellett a gyulladás csökkentését is jelenti [18].”
Cole, L., Chen, L., Sparagna, G. C., Vandel, M., Xiang, B., Dolinsky, V. W., & Hatch, G. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.20.209395
“, determined that type 2 diabetes patients receiving BBR treatment (1 g/day) had significantly reduced fasting glucose (20%), postprandial glucose (25%) and triglyceride levels (35%) after 3 months (Zhang et al., 2008).”
BackgroundInfluentialEvidence of Browning Phenomenon and Its Physiological Relevance in Non-Adipose TissuesPreprint
Ho, D. H.-H., Moola, M. R., Lung, H. L., Yau, K.-H., Chan, H. Y.-S., Yuen, S.-N., Yue, P. Y., & Wong, R. H.-F. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3363905
Efeito da suplementação com berberina nas dislipidemias em humanos: Uma revisão sistemática
Cavalheiro, D. M., Silva, K. D. A., Cardoso, B. E. P., Dias, T. M. D. S., Moura, A. R. D. S., Melo, S. R. D. S., Rios, M. J. B. L., & Morais, J. B. S. (2021) · Research Society and Development · doi:10.33448/rsd-v10i5.14741
Li, W., & Wu, X. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.013
Lian, F., Tian, J., Jin, D., Piao, C., Guo, H., Zhang, J., Li, L., Wu, S., Guo, M., Hong, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-497678/v1
“Previous studies have demonstrated that coptis chinensis balsam pear and rhizoma anemarrhenae can effectively control diabetes by lowering the blood glucose level, reducing lipids, body weight and BMI, and increasing β-cell function [40–42].”
Nahas, R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00032-7
Pharmacognostical, Phytochemical and Pharmacological Review of tinospora cordifolia
Sayyad, S. B., Wakale, N. S., Dhobale, A., & Khaladkar, S. M. (2022) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-4812
Polikistik Over Sendromunun Beslenme Tedavisinde Berberinin Yeri
Döngel, H. E., & Göbel, P. (2022) · Avrasya Sağlık Bilimleri Dergisi · doi:10.53493/avrasyasbd.1085272 · Cited by 1
TCM and Diseases: The Needs for Multi-Omics
Zhao, D. Y., & Zhang, R. (2022) · Translational bioinformatics · doi:10.1007/978-981-19-4771-1_2
Current Strategies of New Drugs for Diabetes Management
Sarfraz, M., Hafizur, R. M., Ullah, H., Sajid, S., Akhtar, R. W., Noreen, M., Perveen, S., & Khan, M. U. (2023) · Frontiers in clinical drug research. Diabetes and obesity · doi:10.2174/9789815123586123070005
Pyrazole containing bioactive phytoconstituents as natural antidiabetic agents: A review
Saini, N., Saini, N., Sirohi, R., Wadhwa, P. K., & Sahu, S. K. (2023) · AIP conference proceedings · doi:10.1063/5.0162911
Unravelling the Potential of Herbal Therapy for Polycystic Ovarian Disorder
Sharma, K., Rahman, N. F., Laskar, S., Ali, S., Ahmed, M. A., Terang, W., Meitei, N. D., Khan, H. A., Ahamad, M. I., Haloi, A. K., et al. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/34761
Ming, J., Yu, X., Xu, X., Wang, L. S., Ding, C., Wang, Z., Xie, X., Li, S., Yang, W., Luo, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15132754
Ming, J., Yu, X., Xu, X., Wang, L., Ding, C., Wang, Z., Xie, X., Li, S., Yang, W., Luo, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15132742
Ming, J., Yu, X., Xu, X., Wang, L., Ding, C., Wang, Z., Xie, X., Li, S., Yang, W., Luo, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15132763
Ming, J., Yu, X., Xu, X., Wang, L. S., Ding, C., Wang, Z., Xie, X., Li, S., Yang, W., Luo, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15132745
Wang, P., Cho, W. C. S., Ye, D., Zhang, Y., & Xiong, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1392930
“…for active rheumatoid arthritis (Lv et al., 2015), red yeast rice for hyperlipidemia (Zhao et al., 2004), and berberine for hyperlipidemia and diabetes (Kong et al., 2004; Zhang et al., 2008); these can help avoid blind screening while reducing the cost and time required for drug development.”
Self-citationBetween Medicines and Nutraceuticals in the Control of Diabetes Mellitus
Park, C., & Baek, Y. (2024) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v12i2.1371
“It 43 .”
Liu, M., He, C., Zhu, T., Jia, X., Zhang, L., Jiang, W., Chi, C., Li, X., Jiang, G., Liu, H., et al. (2024) · Fish Physiology and Biochemistry · doi:10.1007/s10695-024-01362-1
“Berberine (BBR), as a traditional antimicrobial and anti-inflammatory Chinese herbal extract (Tillhon et al. 2012), has also been demonstrated to play a positive role in the treatment of metabolic diseases such as T2DM and fatty liver (Zhang et al. 2008).”
Self-citationPalma, A. B. O., Tonelli, B. Q., de Oliveira, A. L., Silva, A. M., Rodrigues, C. E. D. F., BATISTA, C. M. L., Luiz, J. M. V. A., Martins, J. V. S., & Ribeiro, M. C. M. (2024) · doi:10.22533/at.ed.9602422072
Complementary and Alternative Approaches*
GUTHRIE, D. W., & Shane‐McWhorter, L. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch22
Botanical and Nonbotanical Products for Glucose Lowering
(2021) · American Diabetes Association eBooks · doi:10.2337/9781580407687.ch01
Cao, R., Chen, S., Han, X., & Guo, L. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822407
Sharma, P., Dogra, S. S., Kumar, V., & Patial, V. (2025) · Springer eBooks · doi:10.1007/978-981-96-2960-2_13
Li, Q., Liu, Z., Li, R. F., Zhang, X., Yan, K., Zhu, Y., Wang, X., Han, Z., Hao, W.-J., & Jiang, B. (2025) · Green Synthesis and Catalysis · doi:10.1016/j.gresc.2025.03.007
Aiyegbusi, M. A., Oyegoke, R. A., Quadri, L. A., Omar, S. A., Oloyede, H. O. B., & Yakubu, M. T. (2025) · Comparative Clinical Pathology · doi:10.1007/s00580-025-03691-w
“Thereafter, the animals in group II were injected intraperitoneally (i.p.) with STZ (30 mg/kg body weight) once a week for 2 weeks (ZhaNg et al. 2008), while those in group I were given citrate buffer (pH 4.4; vehicle) at a dose of 1 ml/kg, i.p.”
InfluentialColletti, A., Citi, V., Martelli, A., Pellizzato, M., Riccardi, E. L., & Cravotto, G. (2025) · Scientia Pharmaceutica · doi:10.3390/scipharm93030042
“Among these, berberine, a plant-derived isoquinoline alkaloid, has shown promising results in subjects with IFG and metabolic syndrome [11,12].”
Xing, J., Li, W., & Chen, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1658671
“Berberine (BBR), a plant-derived isoquinoline alkaloid, has been clinically shown to improve glycaemic control and lipid pro fi les in patients with T2D and dyslipidaemia (16) (17).”
Nematollahi, S., Pishdad, G. R., Zakerkish, M., Namjoyan, F., Angali, K. A., & Borazjani, F. (2022) · Figshare · doi:10.6084/m9.figshare.20579778
Jiang, L., Fu, Q., Wang, S., Chen, Y., Li, J., Xiao, Y., Sun, R., Shen, E. A., Wang, J., Zhang, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19603455
Self-citationMing, J., Yu, X., Xu, X., Wang, L., Ding, C., Wang, Z., Xie, X., Li, S., Yang, W., Luo, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15132760
Chen, H., Ye, C., Cai, B., Zhang, F., Wang, X., Zhang, J., Zhang, Z., Guo, Y., & Yao, Q. (2022) · Figshare · doi:10.6084/m9.figshare.19807691
Jiang, L., Fu, Q., Wang, S., Chen, Y., Li, J., Xiao, Y., Sun, R., Shen, E. A., Wang, J., Zhang, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19603458
Self-citationAnap, H. N., Eknath, N. S., Bhagat, J. R., Medge, V. A., Katore, S. V., Pagare, N. V., Kurkute, D. G., Jadhav, S. E., & Bhor, R. J. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3468
Altayyar, S., Preux, P., Aboyans, V., Mroueh, L., Boumédiène, F., & Auditeau, E. (2026) · Journal of Epidemiology and Population Health · doi:10.1016/j.jeph.2025.203159
Liu, X., Liu, Y.-G., Lv, Y., & Deng, B. (2026) · Current Medical Science · doi:10.1007/s11596-026-00168-x
“Both clinical trials and animal studies have consistently demonstrated that BBR exerts glucose-lowering and insulin-sensitizing effects comparable to those of metformin, notably in improving oral glucose tolerance, fasting blood glucose, and HbA1c levels [35, 36].”
Complementary medicine and diabetes induced cellular stress and aging
Tătărîngă, G., & Zbancioc, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44665-8.00020-1
Emerging role of novel candidates for diabetes mitigation
Banerjee, A., Chattopadhyay, R., Chatterjee, S., & Sen, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44665-8.00014-6
Li, Y., Zhou, J., Xu, W., Chen, S., Fu, W., Chen, H., Lei, H., Li, F., Huang, Y., Sun, S., et al. (2026) · Crystal Growth & Design · doi:10.1021/acs.cgd.5c01691
Monoterpene-indole alkaloid from Rinorea yaundensis and antidiabetic potential of its hydrochloride
Khatoon, B., Kawish, M., Zahid, H., iqbal, K., Shah, M. R., & Ali, M. S. (2026) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2022-0118
“The secondary complication associated with diabetes is dyslipidemia [24, 25].”
Filfilan, W. M., & El‐Beeh, M. E. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01910-z
“Previous studies focused on peripheral metabolic endpoints without rigorous interaction analysis (Kong et al. 2009 ; Zhang et al. 2008).”
Jeyakodi, S., Krishnakumar, A., Naik, D. N., Hussain, M. M., & Thomas, J. V. (2026) · International Journal of Clinical Trials · doi:10.18203/2349-3259.ijct20262501
Chi, G., Feng, Y., Jin, S., Li, J., Ren, J., Sun, R., Zhang, W., Xu, X., & Liu, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1804373
Seo, Y., & Woo, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167111
“Effect estimates are therefore more credible as proof of metabolic activity than as a basis for replacing guideline-directed therapy [35,63–65].”
Zhong, M.-Y., Yang, S.-Y., Xu, W.-H., Zhang, Y.-K., & Zhao, J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00544-y
“Berberine, an AMPK activator that also promotes PPARγ deacetylation via SIRT1, lowers blood glucose and lipids in clinical studies, and is available as an OTC supplement in some countries [194, 219, 240].”
Self-citationKovyanova, T. I., Nerush, M. O., Карагодин, В. П., Borodko, D. D., Rozhkova, U. V., Antonov, S. A., & Utkina, A. S. (2026) · Biomedicines · doi:10.3390/biomedicines14081868
“…AMP-activated protein kinase (AMPK), a critical sensor of cellular energy status, leading to reduced hepatic gluconeogenesis, increased peripheral glucose uptake, and inhibition of cholesterol synthesis through down-regulation of the sterol regulatory element-binding protein (SREBP) pathway [55].”
Harnessing Medicinal Plants Through Advanced Drug Delivery: A New Era in Type 2 Diabetes Management
Dadhich, A., Sharma, V., Sharma, S., Bawari, S., & Sivanesan, I. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091100
Sinha, A., Kolmetzky, D. W., Tomar, D., & Jadiya, P. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104402
“…via MCU inhibition, limits m Ca 2 + overload, and attenuates mitochondrial dysfunction and apoptosis [144,145] Attenuates profibrotic remodeling and fibrosis-associated signaling pathways [146] Improves endothelial function and attenuates vascular dysfunction in experimental HFpEF models [147,148]”
Tanveer, A., Singh, A., Upadhayay, A. K., Singh, S., Mani, A., & Singh, H. (2026) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-026-04813-w
Li, T., Danilova, I. G., Rakhov, I. A., & Sokolova, K. V. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02084-2
Gut microbiota as a therapeutic target of traditional Chinese medicines in metabolic disorders
Bairagee, D., Sharma, L., Panchawat, S., & Darwhekar, G. N. (2026) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-026-00928-z
Alanazi, S. M., Al‐kuraishy, H. M., Abdelaziz, A. M., Alasmari, E. M., Yousef, F. M., Mohamed, A. A., Salama, M. M., & Batiha, G. E. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107497
Sun, M., Zhang, W., Nie, S., Li, M., Su, Y., & Song, X. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107504
Kim, B., Kim, J., Kim, G., & Kim, K. (2026) · Pharmaceuticals · doi:10.3390/ph19101572
“Berberine monotherapy has also been shown to increase glucose disposal rate on hyperinsulinemic-euglycemic clamp testing, consistent with improved insulin sensitivity [41].”
Liao, Y., Gui, Y., Li, T., Zhou, Q., Chen, X., & Chen, H. (2026) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x26500795
Malik, T. A., Mushtaq, U., Ghazanfar, K., Ahad, S., Azra Kamili, N., Chishti, M. Z., & Johri, R. K. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122468
毛, 宁. (2026) · Traditional Chinese Medicine · doi:10.12677/tcm.2026.1510600
(2012) · Europe PMC (PubMed Central) · Cited by 62
Metadata
- Authors
- Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., Ren, G., & Ning, G.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Second Military Medical University (CN)
- Department of Endocrinology (J.Y., G.R.), Min-Hang Hospital, Shanghai 201100, People’s Republic of China
- Corresponding author
- Ning, Guang
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2559-2565
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1969395627
- Cited by
- 573
- References
- 23
- Citations by year
- 2026: 30 · 2025: 27 · 2024: 28 · 2023: 33 · 2022: 41 · 2021: 54 · 2020: 46 · 2019: 42 · 2018: 33 · 2017: 23 · 2016: 29 · 2015: 32 · 2014: 34 · 2013: 31 · 2012: 25
- FWCI
- 14.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- berberine, type 2 diabetes, dyslipidemia, glucose-lowering effect, insulin sensitivity, glucose disposal rate, hyperinsulinemic-euglycemic clamp, HbA1c, serum lipids, triglycerides, LDL cholesterol, total cholesterol, plant alkaloids, constipation, drug safety, antidiabetic therapy, lipid-lowering therapy
- MeSH terms
- Adult, Aged, Berberine, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Glycated Hemoglobin, Humans, Insulin, Insulin Resistance, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
